Published by Financial News
In a recent Financial News article, Managing Director and Global Leader of A&M’s Global Transaction Advisory Group, Paul Aversano, discusses the firm’s continued global expansion and paralleled investment in talent. He highlights the firm’s plans to add hundreds of partners as it targets $8 billion in revenue by 2028.
As A&M continues to build on its restructuring foundation, capabilities continue to expand across private equity, corporate finance, and M&A, supporting clients as they navigate increasingly complex transactions and operating environments.
With that expansion, is a continued commitment to talent development.
Aversano emphasizes A&M’s differentiated partnership model, which prioritizes equity-based promotions while maintaining a balanced approach between internal development and strategic external hiring. As he notes, “We’re still promoting more and they’re all equity partners. I do expect that to continue.”
Read the full article in Financial News
Canada’s Private Capital Outlook 2026: Infrastructure, Insight, and Operational Alpha
May 19, 2026
Canadian private capital enters 2026 in a state of disciplined optimism. The environment is more selective, more data-driven, and significantly more execution-focused than in prior cycles.
Infrastructure Pulse Survey Report: Spring 2026, North America and Europe
May 14, 2026
The Infrastructure Pulse Survey Report for Spring 2026, published by Alvarez & Marsal in collaboration with the Global Infrastructure Investor Association (GIIA), offers an insight into how investors across North America and Europe are reading the current investment landscape through a period of macroeconomic and geopolitical uncertainty.
Alvarez & Marsal Continues to Strengthen Transaction Advisory Practice in Australia with Senior Talent
May 13, 2026
Alvarez & Marsal (A&M), a leading global professional services firm, today announced the appointment of Sydney-based Roshan Emmanuel as a Managing Director within its Global Transaction Advisory Group (Global TAG), underscoring the firm’s rapid growth and continued investment in the Australian market.
Carving Out Success: Life Sciences Companies Are Rationalizing Portfolios by Divesting Non-Core Assets
May 12, 2026
Historically, large healthcare and life sciences corporations have focused deal activity on a breadth of diverse assets. However, the landscape is undergoing significant transformation as businesses shift to rationalize their portfolios and invest in fewer core areas.
